Reported Q: Q2 2024 Rev YoY: -48.9% EPS YoY: -34.9% Move: 0.00%
Dime Community Bancshares
DCOMG
$25.85 0.00%
Exchange NASDAQ Sector Financial Services Industry Banks Regional
Q2 2024
Published: Jun 30, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for DCOMG

Reported

Report Date

Jun 30, 2024

Quarter Q2 2024

Revenue

81.73M

YoY: -48.9%

EPS

0.43

YoY: -34.9%

Market Move

0.00%

Previous quarter: N/A

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $81.73M down 48.9% year-over-year
  • EPS of $0.43 decreased by 34.9% from previous year
  • Gross margin of 208.2%
  • Net income of 18.48M
  • "The momentum in our business is strong and we grew core deposits by over $300 million and business loans by over $200 million." - Stuart Lubow
DCOMG
Company DCOMG

Swipe to view all report sections

Executive Summary

Dime Community Bancshares reported a solid Q2 2024 showing meaningful earnings momentum driven by aggressive core deposit accumulation and solid business loan growth. The company disclosed a 20 basis point expansion in net interest margin (NIM) in the quarter, supported by a reduction in wholesale funding and strong deposit inflows despite a challenging rate backdrop. Management emphasized that the first half of 2024 represented a trough in NII/NIM and signaled a structural, multi-year path to higher NIM as rate cuts materialize and legacy loan portfolios reprice in 2025–2026. The bank also highlighted capital strength, with a CET1 ratio above 10% and a total capital ratio of 14.5%, placing it at the top end of its local peer group. Asset quality remained solid, with NPAs down 29% QoQ and a planned 10-Q to show further improvement in classified assets.

Beyond the near-term margin trajectory, Dime outlined a deliberate, organic growth agenda including onboarding of additional deposit-gathering teams, expansion of the healthcare and not-for-profit lending verticals, and a Westchester County branch approval to broaden market reach. Management expects 3Q run-rate expenses of ~$57 million with very modest growth in 2025, supported by efficiency initiatives. The combination of ongoing balance-sheet diversification (middle-market C&I, healthcare, residential), a robust funding position, and a meaningful 2H25–26 repricing opportunity underpins an improving long-term profitability profile, albeit with sensitivity to rate moves and competitive funding dynamics.

Key Performance Indicators

Revenue
Decreasing
81.73M
QoQ: -52.23% | YoY: -48.94%
Gross Profit
Increasing
170.14M
2.08% margin
QoQ: -0.54% | YoY: 6.30%
Operating Income
Decreasing
33.32M
QoQ: 21.99% | YoY: -17.21%
Net Income
Decreasing
18.48M
QoQ: 5.99% | YoY: -31.76%
EPS
Decreasing
0.43
QoQ: 4.88% | YoY: -34.85%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2026 184.75 0.76 +126.1% View
Q1 2025 171.42 0.45 +0.2% View
Q4 2024 131.12 -0.54 -21.4% View
Q3 2024 171.74 0.29 +4.1% View
Q2 2024 81.73 0.43 -48.9% View